Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $166,024 |
Sells | 14 | $380,390 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Mar 2024 16:24 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 04 Mar 2024 | Sale | 2,447 | 7.77 | 19,013 | D |
30 Jan 2024 16:01 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 29 Jan 2024 | Sale | 1,849 | 5 | 9,245 | D |
10 Jan 2024 16:30 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | 09 Jan 2024 | Sale | 10,874 | 4.37 | 47,519 | D |
10 Jan 2024 16:30 | FATE | FATE THERAPEUTICS INC | VALAMEHR BAHRAM | Chief R&D Officer | 09 Jan 2024 | Sale | 11,271 | 4.38 | 49,367 | D |
10 Jan 2024 16:29 | FATE | FATE THERAPEUTICS INC | WOLCHKO J SCOTT | President and CEO | 09 Jan 2024 | Sale | 14,391 | 4.37 | 62,889 | D |
10 Jan 2024 16:29 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 09 Jan 2024 | Sale | 7,028 | 4.37 | 30,712 | D |
03 Jan 2024 16:03 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 02 Jan 2024 | Sale | 5,182 | 3.66 | 18,966 | D |
28 Dec 2023 21:30 | FATE | FATE THERAPEUTICS INC | REDMILE GROUP, LLC | Director , 10% | 26 Dec 2023 | Purchase | 44,630 | 3.72 | 166,024 | I |
19 Dec 2023 16:01 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 18 Dec 2023 | Sale | 1,585 | 3.5 | 5,548 | D |
13 Nov 2023 16:01 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | 09 Nov 2023 | Sale | 24,363 | 2.4 | 58,471 | D |
21 Aug 2023 16:02 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 18 Aug 2023 | Sale | 4,718 | 2.8 | 13,210 | D |
07 Aug 2023 16:01 | FATE | FATE THERAPEUTICS INC | XU YUAN | Director | 04 Aug 2023 | Sale | 632 | 3.71 | 2,345 | D |
06 Jul 2023 17:19 | FATE | FATE THERAPEUTICS INC | POWL BRIAN T. | Chief Commercial Officer | 05 Jul 2023 | Sale | 3,854 | 4.87 | 18,769 | D |
06 Jul 2023 17:18 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 05 Jul 2023 | Sale | 5,182 | 4.83 | 25,029 | D |
15 Jun 2023 16:05 | FATE | FATE THERAPEUTICS INC | XU YUAN | Director | 14 Jun 2023 | Sale | 3,460 | 5.58 | 19,307 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)